These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32536434)

  • 21. Medication Use Among Nursing Home Residents With Severe Dementia: Identifying Categories of Appropriateness and Elements of a Successful Intervention.
    Kröger E; Wilchesky M; Marcotte M; Voyer P; Morin M; Champoux N; Monette J; Aubin M; Durand PJ; Verreault R; Arcand M
    J Am Med Dir Assoc; 2015 Jul; 16(7):629.e1-17. PubMed ID: 25979776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pilot study: incorporation of pharmacogenetic testing in medication therapy management services.
    Haga SB; Allen LaPointe NM; Moaddeb J; Mills R; Patel M; Kraus WE
    Pharmacogenomics; 2014 Nov; 15(14):1729-1737. PubMed ID: 25493566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contribution of Pharmacogenetic Testing to Modeled Medication Change Recommendations in a Long-Term Care Population with Polypharmacy.
    Sugarman EA; Cullors A; Centeno J; Taylor D
    Drugs Aging; 2016 Dec; 33(12):929-936. PubMed ID: 27826798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The OptimaMed intervention to reduce inappropriate medications in nursing home residents with severe dementia: results from a quasi-experimental feasibility pilot study.
    Wilchesky M; Mueller G; Morin M; Marcotte M; Voyer P; Aubin M; Carmichael PH; Champoux N; Monette J; Giguère A; Durand P; Verreault R; Arcand M; Kröger E
    BMC Geriatr; 2018 Sep; 18(1):204. PubMed ID: 30180821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Opportunities for Germline Pharmacogenetics and Management of Drug-Drug Interactions in Patients With Advanced Solid Cancers.
    Shugg T; Ly RC; Rowe EJ; Philips S; Hyder MA; Radovich M; Rosenman MB; Pratt VM; Callaghan JT; Desta Z; Schneider BP; Skaar TC
    JCO Precis Oncol; 2022 Feb; 6():e2100312. PubMed ID: 35201852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Additional Utility of Pharmacogenomics (PGx) Panel Testing in a CYP2D6 Normal Metabolizer with a History of Breast Cancer.
    Schuh MJ
    Innov Pharm; 2019; 10(3):. PubMed ID: 34007571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incorporation of pharmacogenetic testing into medication therapy management.
    Haga SB; Moaddeb J; Mills R; Patel M; Kraus W; Allen LaPointe NM
    Pharmacogenomics; 2015 Nov; 16(17):1931-41. PubMed ID: 26555559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of pharmacogenomic testing on pharmacotherapy decision making in patients with symptoms of depression in an interprofessional primary care clinic.
    Roscizewski L; Henneman A; Snyder T
    J Am Pharm Assoc (2003); 2022; 62(2):569-574.e1. PubMed ID: 34801407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug therapy problems and contributing factors in the management of heart failure patients in Jimma University Specialized Hospital, Southwest Ethiopia.
    Niriayo YL; Kumela K; Kassa TD; Angamo MT
    PLoS One; 2018; 13(10):e0206120. PubMed ID: 30352096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacogenetic profiling via genome sequencing in children with medical complexity.
    Pan A; Scodellaro S; Khan T; Ushcatz I; Wu W; Curtis M; Cohen E; Cohn RD; Hayeems RZ; Meyn MS; Orkin J; Otal J; Reuter MS; Walker S; Scherer SW; Marshall CR; Cohn I; Costain G
    Pediatr Res; 2023 Mar; 93(4):905-910. PubMed ID: 36167815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacogenetic Testing in a 70-Year-Old Woman with Polypharmacy and Multiple Comorbidities: A Case Report.
    Jessop JP; Russell J; DeJesus A; Bardolia C; Hanna A; Turgeon J; Michaud V; Amin NS
    Am J Case Rep; 2023 Feb; 24():e938850. PubMed ID: 36804920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potentially actionable pharmacogenetic variants and symptom control medications in oncology.
    Patel JN; Boselli D; Jandrisevits EJ; Hamadeh IS; Salem A; Meadors P; Walsh D
    Support Care Cancer; 2021 Oct; 29(10):5927-5934. PubMed ID: 33758969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality of Life and Pain Medication Use in Persons With Advanced Dementia Living in Long-Term Care Facilities.
    van Dam PH; Caljouw MAA; Slettebø DD; Achterberg WP; Husebo BS
    J Am Med Dir Assoc; 2019 Nov; 20(11):1432-1437. PubMed ID: 30982716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacogenomics (PGx) Patient with Mixed Levels of Actionable Variant Evidence.
    Schuh MJ; Crosby S
    Innov Pharm; 2020; 11(2):. PubMed ID: 34007616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implementation of a Standardized Medication Therapy Management Plus Approach within Primary Care.
    Schwartz EJ; Turgeon J; Patel J; Patel P; Shah H; Issa AM; Knowlton OV; Knowlton CH; Bain KT
    J Am Board Fam Med; 2017; 30(6):701-714. PubMed ID: 29180545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacist-Initiated Pre-Emptive Pharmacogenetic Panel Testing with Clinical Decision Support in Primary Care: Record of PGx Results and Real-World Impact.
    van der Wouden CH; Bank PCD; Özokcu K; Swen JJ; Guchelaar HJ
    Genes (Basel); 2019 May; 10(6):. PubMed ID: 31146504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Challenges to integrating pharmacogenetic testing into medication therapy management.
    Haga SB; Allen LaPointe NM; Moaddeb J
    J Manag Care Spec Pharm; 2015 Apr; 21(4):346-52. PubMed ID: 25803768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of the PGx-Passport: A Panel of Actionable Germline Genetic Variants for Pre-Emptive Pharmacogenetic Testing.
    van der Wouden CH; van Rhenen MH; Jama WOM; Ingelman-Sundberg M; Lauschke VM; Konta L; Schwab M; Swen JJ; Guchelaar HJ
    Clin Pharmacol Ther; 2019 Oct; 106(4):866-873. PubMed ID: 31038729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prescribing psychoactive medications in nursing homes: current practice in Singapore.
    Mamun K; Goh-Tan CY; Ng LL
    Singapore Med J; 2003 Dec; 44(12):625-9. PubMed ID: 14770256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Description of drug therapy problem resolution in a statewide care management program.
    Renfro CP; Ferreri SP; Williams N; Clark C; Pfeiffenberger T
    J Am Pharm Assoc (2003); 2017; 57(3S):S289-S292. PubMed ID: 28506381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.